A New Chapter in DLBCL: Uncovering New Treatment Options For Your Patients
EP. 1: Standard of Care for Relapsed/Refractory DLBCL
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 
EP. 2: CAR T in Transplant-Eligible and Transplant-Ineligible DLBCL
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 
EP. 3: L-MIND Study in R/R DLBCL
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 
EP. 4: RE-MIND Study in R/R DLBCL
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 
EP. 5: Phase 2B SADAL Trial in R/R DLBCL
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 
EP. 6: Treatment of R/R DLBCL: Beyond CAR T Therapy
ByJohn M. Burke, MD, Rocky Mountain Cancer Centers,Julio Chavez, MD, Moffitt Cancer Center,Nathan H. Fowler, MD, MD Anderson Cancer Center,Grzegorz S. Nowakowski, MD, Mayo Clinic 